Archives
I was asked about the clinical of thiazides and hyperglycemia. To be honest, studies aren’t that great surrounding this question, and the main ones I’m aware of and could find were very old. Here’s a quick breakdown of a couple of studies on the risk of thiazides contributing to hyperglycemia. The original study that was […]
Read More
I got asked a question the other day about spironolactone. Specifically, how common is gynecomastia with spironolactone? Before I answer that question, let’s take a look at some of the common clinical pearls with spironolactone. Spironolactone classified as a potassium-sparing diuretic, so from that description, we know that we have to monitor for the risk […]
Read More
You will see antiarrhythmics used in clinical practice. They are typically prescribed by cardiovascular specialists, but we wanted to provide an antiarrhythmic comparison chart because as a healthcare professional, you still need to monitor for risks and drug interactions associated with these medications. Patients can develop arrhythmias through a variety of cardiac and non-cardiac factors. […]
Read More
Amiodarone is an older antiarrhythmic drug that you may see used in primary care and geriatrics. I’m well into my latest project on a NEW BOOK involving the prescribing cascade and polypharmacy. I wanted to share a part of it by discussing amiodarone adverse effects. Amiodarone adverse effects include things like ocular toxicity, QTc prolongation, […]
Read More
Sacubitril/valsartan (ARNI) is getting more attention in the guidelines with regards to its use in heart failure (specifically HFrEF). Many patients are already on an ACE and making the transition from an ACE inhibitor to an ARNI is likely something you will come across. In clinical practice, there is a significant risk for angioedema when […]
Read More